Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.

Oncotarget - 30 Oct 2014

Gargiulo Lucía, Copsel Sabrina, Rivero Ezequiel M, Galés Céline, Sénard Jean-Michel, Lüthy Isabel A, Davio Carlos, Bruzzone Ariana

Abstract excerpt

Breast cancer is the most frequent malignancy in women. Several reports demonstrated that adrenergic receptors (ARs) are involved in breast cancer. Here we observed that epinephrine (Epi), an endogenous AR agonist, caused opposite effects in non-tumorigenic (MCF-10A and HBL-100) and tumor cells (...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-2 Receptor Agonists
Share to Cell Adhesion
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epinephrine

Share to Gene Knockdown Techniques

Share to Isoproterenol

Share to MCF-7 Cells

Share to Receptors, Adrenergic, beta-2

Source

Open in PubMed Open full text

Identifiers

PMID: 25375203
DOI: 10.18632/oncotarget.2460
PMCID: PMC4259405

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25375203-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.PMID 25375203Read ↗

The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells.Semantic proximity Read ↗

Divergent label-free cell phenotypic pharmacology of ligands at the overexpressed β₂-adrenergic receptors.Semantic proximity Read ↗

Beta-adrenergic receptors. Relationship of primary structure, receptor function, and regulation.Semantic proximity Read ↗

Profiling the Adrenergic System in Breast Cancer and the Development of MetastasisSemantic proximity Read ↗

Beta 2 adrenergic receptor and mu opioid receptor interact to potentiate the aggressiveness of human breast cancer cell by activating the glycogen synthase kinase 3 signalingSemantic proximity Read ↗

Transcriptional activation of the estrogen receptor.Semantic proximity Read ↗

The Network of Angiotensin Receptors in Breast CancerSemantic proximity Read ↗

Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitroSemantic proximity Read ↗

Beta-2 Adrenergic Receptor Gene Expression in HER2-Positive Early-Stage Breast Cancer Patients: A Post-hoc Analysis of the NCCTG-N9831 (Alliance) TrialSemantic proximity Read ↗

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.Semantic proximity Read ↗

Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcomeSemantic proximity Read ↗

Response-specific antiestrogen resistance in a newly characterized MCF-7 human breast cancer cell line resulting from long-term exposure to trans-hydroxytamoxifenSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.